Galectin Therapeutics Inc. (GALT)

[thefamilyman]

I'm not sure whether the one responsible for those screw ups (with Cohort 2 of Phase1 and the FX trial) was Traber or Czirr. I wanted to believe that it was Czirr and that the management issues were resolved by his termination. But who knows...

One thing is clear, if the CX trial results are not definitive, then we shareholders have had a bad day.

"I bought 2500 shares of GALT yesterday at $2.19 as a statement of my belief that Traber has been the biggest thing wrong with the company for the past 6 years-without his mismanagement of the Phase 1 data release and the whole concept of the FX trial (wasting money that could have been spent on real trials for both psoriasis and atopic dermatitis) this stock would still be trading at $10+ and wouldn't be on the verge of running out of money.

Traber has lost his fight with Jim Czirr and many others on the BOD, he will be gone by next February (as well as his Chairman Puppet Mark Rubin) and will be on to the next company he can screw up." - biotech2010